Dabur India Limited
Indian Pharmaceutical Exporter ยท Ayurvedic & Herbal Products Specialist ยท $1.9M Total Trade ยท DGFT Verified
Dabur India Limited is an Indian pharmaceutical exporter with a total trade value of $1.9M across 6 products in 1 therapeutic categories. Based on 830 verified export shipments from Indian Customs (DGFT) records, Dabur India Limited is the #1 Indian exporter in 3 products including Extract, Arishta, Gutika. Top exports include Extract ($1.1M), Arishta ($590.0K), Churna ($111.2K).
Dabur India Limited โ Export Portfolio & Destination Treemap

Who is Dabur India Limited? โ Company Overview & Market Position
Dabur India Limited, established in 1884 by Dr. S.K. Burman in Kolkata, India, has evolved into a leading multinational consumer goods company specializing in Ayurvedic and natural health care products. The company is headquartered in Ghaziabad, Uttar Pradesh, and operates under the Corporate Identification Number (CIN) L24230UP1986PLC008119. As of March 2020, Dabur employed approximately 7,740 individuals. In the fiscal year ending March 31, 2025, Dabur reported revenues of approximately $1.5 billion, reflecting a 1.3% increase from the previous year. The company's diverse product portfolio includes health supplements, digestive products, hair care, oral care, skin care, home care, and food & beverages, marketed under well-known brands such as Dabur Chyawanprash, Dabur Honey, Dabur Amla, and Real.